A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace

Inclusion Criteria: 1. Healthy male adults aged 19 to 45 (inclusive) years 2. Body weight at least 55 kg and calculated Body Mass Index (BMI) ranging from 18.0 to 25.0 kg/m2 3. Subjects who agreed to voluntarily participate in this study and comply with all the protocol requirements by signing informed consent form 4. Subjects who were deemed as eligible subjects by investigators on their physical examination, laboratory findings, and medical examination by interview. 5. Subject who were not to have a history of drug hypersensitivity or allergic reactions related to antibiotics, etc Exclusion Criteria: 1. Subjects who had a clinically significant disease or a past history of disease 2. Subjects who had a past history of gastrointestinal disease (Crohn's disease, ulcer, acute or chronic pancreatitis, etc.) or surgery (excluding simple appendectomy or hernia surgery) that may have affected to absorption for the study drug. 3. Subjects who had the following laboratory test results at screening; AST, ALT, and total bilirubin ≥ 1.5 times upper limit of normal or CK (Creatine Kinase) \> 2.5 times upper limit of normal 4. Subjects who had history of drug abuse or showed a positive result on a drug screening urine test. 5. Subjects who showed a positive result for a serology test (HBsAg, Anti-HCV , HIV Ab, or VDRL), etc.